Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT04805658

Natural History Study of Retinitis Pigmentosa Type 11

Observational study of patients with retinitis pigmentosa type 11

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Conditions

Retinitis Pigmentosa 11 Congenital, Hereditary, and Neonatal Diseases and Abnormalities Eye Diseases Eye Diseases, Hereditary Genetic Diseases, Inborn Retinal Degeneration Retinal Diseases Retinal Dystrophies Retinitis Retinitis Pigmentosa

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Ophthalmology, Oslo University Hospital

Oslo, 0450, Norway

About this study

Natural history study with clinical examination every 6 months.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Clinical diagnosis of retinitis pigmentosa caused by a disease-causing mutation involving the PRPF31 gene
  • Or disease-causing mutation involving the PRPF31 gene without the clinical diagnosis of retinitis pigmentosa

Exclusion criteria

  • Under 18 years
  • Other types of retinitis pigmentosa

Treatment and study plan

Clinical examinations

Diagnostic Test

Clinical examinations

Primary outcomes

  1. Progression of disease

    Time frame: 24 mounths

    Retinal function measured by functional and structural testing

Sponsors and collaborators

Lead sponsor

Oslo University Hospital

Other

Registry information

Acronym: ReSa

Important dates

Study start
2021
Primary completion
2028
Study completion
2028
First posted
Mar 18, 2021
Registry last updated
Mar 21, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.